T1	Participants 94 135	young women with ovarian hyperandrogenism
T2	Participants 411 492	young women with ovarian hyperandrogenism, a variant of polycystic ovary syndrome
T3	Participants 769 1060	young patients with hyperinsulinemic ovarian hyperandrogenism (n = 40; age, approximately 17 yr; body mass index, approximately 22 kg/m(2)); all participants started on metformin (850 mg/d) and a fourth-generation contraceptive (ethinylestradiol 30 microg plus drospirenone 3 mg, 21 d/month)
T4	Participants 2053 2095	young women with polycystic ovary syndrome
